Lumbard Investment Counseling »

SPDR S&P Biotech shares owned by Lumbard Investment Counseling

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Lumbard Investment Counseling from 13F filings

Historical chart of Lumbard Investment Counseling investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by Lumbard Investment Counseling consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by Lumbard Investment Counseling

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.6M 52k 89.29

More positions owned by Lumbard Investment Counseling

Spdr Bloomberg 1-3 Month T-bill Etf Etf (BIL)
Metlife Stock (MET)
Vanguard International High Dividend Yield Etf Etf (VYMI)
Petroleo Brasileiro Sa Petrobr Adr (PBR)
Invesco S&p 500 Equal Weight Etf Etf (RSP)
Kinder Morgan Inc Del Stock (KMI)
Prudential Finl Stock (PRU)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
New Fortress Energy Inc Com Cl A Stock (NFE)
Lockheed Martin Corp Stock (LMT)
Northrop Grumman Corp Stock (NOC)
Franklin Ftse Brazil Etf Etf (FLBR)
Valaris Ltd Cl A Stock (VAL)
Goldman Sachs Group Stock (GS)
Ishares Msci Indonesia Etf Etf (EIDO)

View all positions for Lumbard Investment Counseling

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Citadel Advisors
Millennium Management
UBS Group
Bank of America Corporation
Citigroup
venBio Select Advisor
Jpmorgan Chase & Co
Bnp Paribas Arbitrage, Snc
Nantahala Capital Management
Healthcare Of Ontario Pension Plan Trust Fund
Moore Capital Management
Barclays
Perceptive Advisors
Gts Securities

View all funds holding SPDR S&P Biotech